Bath & Body Works, Inc. BBWI

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

Bath & Body Works (BBWI) just rolled out Essentials, a sensitive-skin-focused body care line with hypoallergenic formulas and soft fragrances, giving investors fresh data on how the retailer is expanding within its core categories. Recent trading tells a different story than the product buzz. Bath & Body Works shares have fallen about 30% over the past 90 days and the 1-year total shareholder return is down roughly 35%, signalling fading momentum, even as Essentials and holiday launches aim...

Buyout sponsors hunt for cash flow, equity discounts, and operational levers that management left on the table. Three public companies are sitting on all three right now, and at least one trades at a valuation small enough for a mid-market fund to write the check alone.

Bath & Body Works Essentials Bath & Body Works is launching Essentials, a new body care franchise Dr. Michelle Henry Bath & Body Works is partnering with board-certified dermatologist Dr. Michelle Henry to help consumers better understand the ingredients in Essentials What You Should Know: Bath & Body Works is launching Essentials, a new body care franchise made for sensitive skin, available in stores and online in the U.S. and Canada on Sept. 28 and more international markets next year.Every pr

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Investing.com -- Bath & Body Works Inc. (NYSE:BBWI) shares advanced 2.3% in extended trading Thursday following reports that activist investor Barington Capital Group has built a fresh position in the specialty retailer and is urging its board to explore a strategic sale. Barington Chief Executive Officer James Mitarotonda disclosed a stake of approximately one million shares in an interview with Bloomberg, signaling a renewed intervention at the Columbus, Ohio-based company he previously target

CEO Daniel Heaf said a reduction in distressed inventory came from “buying our seasonal business correctly.”

A number of stocks fell in the afternoon session after surging crude oil prices and a sharp jump in benchmark Treasury yields stoked renewed concerns over inflation and demand destruction. WTI crude rose to about $90 a barrel after renewed U.S.-Iran strikes disrupted shipping near Hormuz, according to CNBC. Bloomberg reported that rising oil prices are stoking inflation fears and reducing appetite for riskier assets as investors worry the Fed may keep rates higher. Higher pump and freight costs

Bath & Body Works, Inc. (NYSE:BBWI) returned the North American direct business to growth in Q2 2026, marking the first year-over-year increase since 2021. Direct net sales rose 3% to $275 million, helped by a lower free-shipping threshold and digital improvements. However, total net sales at Bath & Body Works, Inc. (NYSE:BBWI) declined 2.3% to […]

Bath & Body Works (NYSE:BBWI) introduced its new Reserve Collection home fragrance franchise, centered on modern fragrance delivery and elevated design. The Reserve Collection expands the company’s home fragrance lineup with a focus on design led products aimed at style conscious consumers. The launch highlights Bath & Body Works’ effort to align its portfolio with evolving home fragrance preferences and premium aesthetics. This focus on design driven home and personal fragrance is shared...

The retailer posted net sales of $1.51bn for the quarter ended 1 August, down 2.3% from a year earlier.

The retailer expects to see continued gains in the channel in the back half of the year through 2027.

Personal care and home fragrance retailer Bath & Body Works (NYSE:BBWI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales fell by 2.3% year on year to $1.51 billion. Its non-GAAP profit of $0.62 per share was significantly above analysts’ consensus estimates.

Bath & Body Works Inc (BBWI) exceeds Q2 expectations with adjusted EPS of $0.62, driven by tariff refunds and digital growth, while navigating ongoing store traffic pressures.

Although the revenue and EPS for Bath & Body Works (BBWI) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.